A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. That's about 60 pounds on average. The people also did three months of intensive diet and exercise.
FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight.
The results, which were also presented Sunday at a medical conference, confirm that the drug made by Eli Lilly & Co. has the potential to be one of the most powerful medical treatments for obesity to date, outside experts said.Pharmacist shortages and heavy workloads challenge drugstores heading into their busy season“Any way you slice it, it’s a quarter of your total body weight,” said Dr. Caroline Apovian, who treats obesity at Brigham and Women’s Hospital and wasn’t involved in the study.
Tirzepatide targets two hormones that kick in after people eat to regulate appetite and the feeling of fullness communicated between the gut and the brain. Semaglutide, the drug used in Ozempic and Wegovy, targets one of those hormones. Participants in both groups lost about 7% of their body weight, or almost 17 pounds , during the diet-and-exercise phase. Those who received the drug went on to lose an additional 18.4% of initial body weight, or about 44 pounds more, on average. Those who received the dummy shots regained about 2.5% of their initial weight, or 6 pounds .
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study findsA new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight.
Lire la suite »
UnitedHealth earnings beat estimates as company again raises guidanceInsurance giant takes aim at weight-loss drug prices, saying cost will limit adoption
Lire la suite »
Everything John Mulaney Has Said About Drug Addiction, RecoveryJohn Mulaney checked into a treatment center in December 2020 after relapsing in his struggle with addiction — all the details
Lire la suite »
PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapyA novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth.
Lire la suite »
Inflation Reduction Act’s Drug Pricing Provisions May Lead To Lower Prices In OncologyI'm an independent healthcare analyst with more than 24 years of experience analyzing healthcare and pharmaceuticals.
Lire la suite »
‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
Lire la suite »